• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制剂诱发的血管性水肿:一例报告及治疗选择综述

Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options.

作者信息

Ameer Muhammad Atif, Mushtaq Javaria, Chaudhry Haroon, Patel Nimi, Khan Somia Ilyas

机构信息

Medicine, Punjab Rangers Teaching Hospital, Lahore, PAK.

Cell Biology and Neuroscience, Rowan University, Stratford, USA.

出版信息

Cureus. 2023 Jun 12;15(6):e40320. doi: 10.7759/cureus.40320. eCollection 2023 Jun.

DOI:10.7759/cureus.40320
PMID:37448396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10337988/
Abstract

Angiotensin-converting enzyme inhibitors (ACEIs) are widely used for heart failure, renal failure, diabetic nephropathy, stroke, arterial hypertension, and a number of other cardiovascular or related conditions. ACEI-induced angioedema is a rare entity but can result in life-threatening emergencies. It mainly occurs in patients starting on ACEI as an antihypertensive. We present a case of lisinopril-induced angioedema in an African American patient managed in the emergency department. After appropriate evaluation, the patient was declared safe to be observed in the emergency department. Intubation was not performed. Early identification of angioedema is paramount, and emergency physicians should maintain airways or intubate such patients if indicated. There should be a high level of suspicion of angioedema in patients taking ACEIs if they present with symptoms of respiratory compromise.

摘要

血管紧张素转换酶抑制剂(ACEIs)被广泛用于治疗心力衰竭、肾衰竭、糖尿病肾病、中风、动脉高血压以及许多其他心血管疾病或相关病症。ACEI 引起的血管性水肿是一种罕见的情况,但可能导致危及生命的紧急状况。它主要发生在开始使用 ACEI 作为抗高血压药物的患者中。我们报告一例在急诊科接受治疗的非裔美国患者因赖诺普利引起血管性水肿的病例。经过适当评估,该患者被判定在急诊科观察是安全的,未进行插管。血管性水肿的早期识别至关重要,如果有指征,急诊医生应维持此类患者的气道或进行插管。服用 ACEIs 的患者如果出现呼吸功能不全的症状,应高度怀疑血管性水肿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64c/10337988/3f5bc2b89ad1/cureus-0015-00000040320-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64c/10337988/306764b0116d/cureus-0015-00000040320-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64c/10337988/3f5bc2b89ad1/cureus-0015-00000040320-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64c/10337988/306764b0116d/cureus-0015-00000040320-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64c/10337988/3f5bc2b89ad1/cureus-0015-00000040320-i02.jpg

相似文献

1
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options.血管紧张素转换酶抑制剂诱发的血管性水肿:一例报告及治疗选择综述
Cureus. 2023 Jun 12;15(6):e40320. doi: 10.7759/cureus.40320. eCollection 2023 Jun.
2
Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature.迟发性血管紧张素转换酶诱导的血管性水肿:病例报告及文献综述
J Okla State Med Assoc. 1999 Feb;92(2):71-3.
3
Angiotensin-converting enzyme inhibitors and angioedema.血管紧张素转化酶抑制剂与血管性水肿。
Allergy Asthma Immunol Res. 2010 Jul;2(3):195-8. doi: 10.4168/aair.2010.2.3.195. Epub 2010 May 6.
4
Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.简要综述:血管紧张素转换酶抑制剂与血管性水肿:麻醉相关问题
Can J Anaesth. 2006 Oct;53(10):994-1003. doi: 10.1007/BF03022528.
5
Geriatric Pharmacotherapy Case Series: Recurrent Angioedema Following Discontinuation of ACE Inhibitor Therapy.老年患者药物治疗病例系列:停用血管紧张素转换酶抑制剂治疗后反复发生血管性水肿。
Sr Care Pharm. 2023 Jan 1;38(1):16-20. doi: 10.4140/TCP.n.2023.16.
6
Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.血管紧张素转换酶抑制剂所致血管性水肿:文献综述
J Clin Hypertens (Greenwich). 2017 Dec;19(12):1377-1382. doi: 10.1111/jch.13097. Epub 2017 Oct 10.
7
Possible angiotensin-converting enzyme inhibitor (ACEI)-induced small bowel angioedema.可能由血管紧张素转换酶抑制剂(ACEI)引起的小肠血管性水肿。
J Pharm Pract. 2011 Dec;24(6):564-7. doi: 10.1177/0897190011406126.
8
Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria.血管紧张素转换酶抑制剂(ACEI)诱发血管性水肿研究者评定量表的开发与验证及拟议的出院标准
BMC Health Serv Res. 2017 May 22;17(1):366. doi: 10.1186/s12913-017-2274-4.
9
Angiotensin-Converting Enzyme Inhibitor Angioedema.血管紧张素转换酶抑制剂相关性血管水肿。
Adv Emerg Nurs J. 2020 Apr/Jun;42(2):103-107. doi: 10.1097/TME.0000000000000294.
10
Emergency department evaluation of patients with angiotensin converting enzyme inhibitor associated angioedema.血管紧张素转化酶抑制剂相关性血管性水肿患者的急诊科评估。
Am J Emerg Med. 2020 Dec;38(12):2596-2601. doi: 10.1016/j.ajem.2019.12.058. Epub 2020 Jan 7.

本文引用的文献

1
A Case Report of Delayed Post-operative Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use.一例与使用血管紧张素转换酶抑制剂相关的术后延迟性血管性水肿病例报告。
Cureus. 2021 Oct 15;13(10):e18800. doi: 10.7759/cureus.18800. eCollection 2021 Oct.
2
Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell-Mediated Angioedema.缓激肽介导的血管性水肿与肥大细胞介导的血管性水肿在机制和临床表型方面的差异与相似之处。
Clin Rev Allergy Immunol. 2021 Aug;61(1):40-49. doi: 10.1007/s12016-021-08841-w. Epub 2021 Feb 3.
3
Perindopril-induced angioedema of the lips and tongue: a case report.
培哚普利引起的唇舌血管性水肿:一例报告
J Med Case Rep. 2018 Dec 5;12(1):359. doi: 10.1186/s13256-018-1910-x.
4
Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment.血管性水肿与急诊医学:从病理生理学到诊断与治疗。
Eur J Intern Med. 2019 Jan;59:8-13. doi: 10.1016/j.ejim.2018.09.004. Epub 2018 Sep 13.
5
Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.血管紧张素转换酶抑制剂用于各种适应证的处方模式:一项基于英国人群的研究。
Br J Clin Pharmacol. 2018 Oct;84(10):2365-2372. doi: 10.1111/bcp.13692. Epub 2018 Jul 24.
6
ACE Inhibitor-Induced Angioedema: a Review.血管紧张素转换酶抑制剂相关性血管水肿:综述。
Curr Hypertens Rep. 2018 Jun 8;20(7):55. doi: 10.1007/s11906-018-0859-x.
7
Hereditary and Acquired Angioedema: Heterogeneity of Pathogenesis and Clinical Phenotypes.遗传性和获得性血管性水肿:发病机制和临床表型的异质性
Int Arch Allergy Immunol. 2018;175(3):126-135. doi: 10.1159/000486312. Epub 2018 Jan 26.
8
Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.血管紧张素转换酶抑制剂所致血管性水肿:文献综述
J Clin Hypertens (Greenwich). 2017 Dec;19(12):1377-1382. doi: 10.1111/jch.13097. Epub 2017 Oct 10.
9
Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.血管紧张素转换酶抑制剂所致血管性水肿的新型治疗方法:当前证据的系统评价
J Emerg Med. 2017 Nov;53(5):662-679. doi: 10.1016/j.jemermed.2017.05.037. Epub 2017 Sep 20.
10
Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors.与严重复发性血管性水肿相关的危险因素:一种与血管紧张素转换酶抑制剂有关的流行病。
Laryngoscope. 2014 Nov;124(11):2502-7. doi: 10.1002/lary.24777. Epub 2014 Jun 17.